|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
WO1990001063A1
(en)
|
1988-07-23 |
1990-02-08 |
Delta Biotechnology Limited |
New secretory leader sequences
|
|
AU632065B2
(en)
|
1988-09-23 |
1992-12-17 |
Novartis Vaccines And Diagnostics, Inc. |
Cell culture medium for enhanced cell growth, culture longevity and product expression
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
US5429746A
(en)
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
|
AT403989B
(de)
|
1996-09-16 |
1998-07-27 |
Immuno Ag |
Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
|
|
EP0950067B1
(en)
|
1996-11-27 |
2007-08-29 |
Genentech, Inc. |
Affinity purification of polypeptide on protein a matrix
|
|
US6022952A
(en)
|
1998-04-01 |
2000-02-08 |
University Of Alberta |
Compositions and methods for protein secretion
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
CA2350226C
(en)
|
1998-11-20 |
2012-04-24 |
Fuso Pharmaceutical Industries, Ltd. |
Protein expression vector and utilization thereof
|
|
JP2002538841A
(ja)
|
1999-03-18 |
2002-11-19 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
２７個のヒト分泌タンパク質
|
|
US7306799B2
(en)
|
1999-06-08 |
2007-12-11 |
Regeneron Pharmaceuticals, Inc. |
Use of VEGF inhibitors for treatment of eye disorders
|
|
CN100523187C
(zh)
|
1999-06-08 |
2009-08-05 |
里珍纳龙药品有限公司 |
具有改善的药物动力学特性的修饰嵌合多肽
|
|
US7070959B1
(en)
|
1999-06-08 |
2006-07-04 |
Regeneron Pharmaceuticals, Inc. |
Modified chimeric polypeptides with improved pharmacokinetic properties
|
|
US7303746B2
(en)
|
1999-06-08 |
2007-12-04 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating eye disorders with modified chimeric polypeptides
|
|
AU2003210802B2
(en)
|
2002-02-05 |
2009-09-10 |
Genentech Inc. |
Protein purification
|
|
DE602004026343D1
(de)
|
2003-10-24 |
2010-05-12 |
Amgen Inc |
Verfahren zur aufreinigung von proteinen in einer durchflussfraktion aus der chromatographie mit hydrophoben wechselwirkungen
|
|
TWI372763B
(en)
*
|
2005-06-17 |
2012-09-21 |
Wyeth Llc |
Methods of purifying anti a beta antibodies
|
|
FR2894146B1
(fr)
|
2005-12-07 |
2008-06-06 |
Ifremer |
Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus a des fins d'ingenierie des tissus conjonctifs non mineralises
|
|
WO2007109163A2
(en)
|
2006-03-16 |
2007-09-27 |
Amgen Inc |
Wash buffer and method of using
|
|
US7998927B2
(en)
|
2006-06-23 |
2011-08-16 |
Aegis Therapeutics, Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
AU2008206923A1
(en)
|
2007-01-17 |
2008-07-24 |
Merck Serono S.A. |
Process for the purification of Fc-containing proteins
|
|
CL2008002054A1
(es)
|
2007-07-17 |
2009-05-29 |
Hoffmann La Roche |
Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
|
|
EP2321338A1
(en)
|
2008-08-14 |
2011-05-18 |
Merck Sharp & Dohme Corp. |
Methods for purifying antibodies using protein a affinity chromatography
|
|
AU2009347206C1
(en)
|
2008-10-20 |
2016-12-08 |
Abbvie Inc. |
Isolation and purification of antibodies using Protein A affinity chromatography
|
|
BRPI0919879A2
(pt)
|
2008-10-29 |
2016-02-16 |
Wyeth Llc |
métodos para purificação de moléculas de ligação a antígeno de domínio único
|
|
WO2011038894A1
(en)
|
2009-10-01 |
2011-04-07 |
F. Hoffmann-La Roche Ag |
Protein a chromatography
|
|
ES2813398T3
(es)
*
|
2009-10-20 |
2021-03-23 |
Abbvie Inc |
Aislamiento y purificación de anticuerpos anti-IL-13 usando cromatografía de afinidad a Proteína A
|
|
EP2513134B1
(en)
|
2009-12-18 |
2017-09-06 |
Novartis AG |
Wash solution and method for affinity chromatography
|
|
CN103429609A
(zh)
|
2010-12-08 |
2013-12-04 |
安姆根有限公司 |
在氨基酸存在下的离子交换层析
|
|
TW201823460A
(zh)
|
2012-05-29 |
2018-07-01 |
美商再生元醫藥公司 |
生產細胞株增強子
|
|
AU2015273049B2
(en)
*
|
2014-06-13 |
2019-11-14 |
Lupin Limited |
Process for the purification of TNFR:Fc fusion protein
|
|
EP3236772A4
(en)
*
|
2014-12-22 |
2018-10-17 |
Alexion Pharmaceuticals, Inc. |
Methods of purifying recombinant proteins
|
|
TW201702380A
(zh)
*
|
2015-02-27 |
2017-01-16 |
再生元醫藥公司 |
宿主細胞蛋白質修飾
|
|
AU2016261854B2
(en)
|
2015-05-12 |
2022-05-26 |
Regeneron Pharmaceuticals, Inc. |
Multimeric protein purity determination
|
|
CN106749660B
(zh)
*
|
2016-12-27 |
2020-02-14 |
嘉和生物药业有限公司 |
单克隆抗体下游纯化过程中有效去除宿主蛋白的方法
|
|
DK3668985T3
(da)
|
2017-08-17 |
2021-09-20 |
Just Evotec Biologics Inc |
Fremgangsmåde til rensning af glycosyleret protein fra værtscellegalectiner og andre urenheder
|
|
JP2022520793A
(ja)
*
|
2019-02-15 |
2022-04-01 |
ジャスト－エヴォテック バイオロジックス、インコーポレイテッド |
自動バイオ製造システム、施設、及びプロセス
|